CDRH to Strengthen Postmarket Surveillance, Plans Proactive Electronic Data Analysis
Building on the enhanced tracking abilities that will be created by implementation of unique device identifiers (UDI), the FDA plans to begin rolling out by year’s end an enhanced postmarket surveillance program for medical devices.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.